First City Capital Management’s Array Biopharma Inc ARRY Stock Holding History

First City Capital Management’s Portfolio ARRY Stock Details ARRY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-2,000	Closed	-$5.9K	–	579
2016 Q1	$5.9K	Hold	2,000	–	–	﹤0.01%	524
2015 Q4	$8.44K	Hold	2,000	–	–	0.01%	486
2015 Q3	$9.12K	Hold	2,000	–	–	0.01%	463
2015 Q2	$14.4K	Hold	2,000	–	–	0.01%	405
2015 Q1	$14.7K	Hold	2,000	–	–	0.01%	395
2014 Q4	$9.46K	Hold	2,000	–	–	0.01%	458
2014 Q3	$7.14K	Hold	2,000	–	–	0.01%	468
2014 Q2	$9.12K	Hold	2,000	–	–	0.01%	460
2014 Q1	$9.4K	Buy	+2,000	New	+$10.1K	0.01%	445

Other funds holding ARRY

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

First City Capital Management's ARRY Position: Q2 2016 in Review

First City Capital Management sold out of Array Biopharma Inc (ARRY) in Q2 2016, closing a stake of 2,000 shares — an estimated $5.9K sold.

First City Capital Management first reported a position in ARRY in Q1 2014 and held it in 9 quarters. The position peaked at $14.7K in Q1 2015. 128 funds tracked by Wall St. Rank hold ARRY as of Q2 2016.

First City Capital Management reported no remaining Array Biopharma Inc position as of Q2 2016 after selling out during the quarter.
First City Capital Management sold 2,000 Array Biopharma Inc shares in Q2 2016, an estimated $5.9K.
First City Capital Management first reported a position in Array Biopharma Inc in Q1 2014 and held it in 9 quarters.
First City Capital Management's Array Biopharma Inc position peaked at $14.7K in Q1 2015.
128 funds tracked by Wall St. Rank held Array Biopharma Inc as of Q2 2016.

Based on First City Capital Management's 13F filing for Q2 2016, filed 16 Aug 2016.